4.7 Article

The kinase TBK1 functions in dendritic cells to regulate T cell homeostasis, autoimmunity, and antitumor immunity

Journal

JOURNAL OF EXPERIMENTAL MEDICINE
Volume 214, Issue 5, Pages 1493-1507

Publisher

ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20161524

Keywords

-

Funding

  1. National Institutes of Health/National Cancer Institute [P30CA016672]
  2. Cancer Prevention and Research Institute of Texas [RP150235]
  3. National Institutes of Health [GM84459]
  4. Center for Inflammation and Cancer at the MD Anderson Cancer Center
  5. National Natural Science Foundation of China [81571545]
  6. Recruitment Program of Global Experts of China

Ask authors/readers for more resources

Dendritic cells (DCs) are crucial for mediating immune responses but, when deregulated, also contribute to immunological disorders, such as autoimmunity. The molecular mechanism underlying the function of DCs is incompletely understood. In this study, we have identified TANK-binding kinase 1 (TBK1), a master innate immune kinase, as an important regulator of DC function. DC-specific deletion of Tbk1 causes T cell activation and autoimmune symptoms and also enhances antitumor immunity in animal models of cancer immunotherapy. The TBK1-deficient DCs have up-regulated expression of co-stimulatory molecules and increased T cell-priming activity. We further demonstrate that TBK1 negatively regulates the induction of a subset of genes by type I interferon receptor (IFNAR). Deletion of IFNAR1 could largely prevent aberrant T cell activation and autoimmunity in DC-conditional Tbk1 knockout mice. These findings identify a DC-specific function of TBK1 in the maintenance of immune homeostasis and tolerance.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available